Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
License option agreement with Novartis for target-specific access to TRACER™ next-generation AAV capsids for potential use…
Month: March 2022
Xüdle’s New Profitability Guide Helps Wineries Increase Sales in Current Economic Climate
New e-book provides wineries of all sizes with tips to improve bottom line revenue and…
RETRANSMISSION: HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Orbs Expands to Fantom to Enhance L3 DeFi Capabilities
Orbs continues to push the boundaries of multi-chain interoperability as part of its Orbs 3.0…
Yuanxi Creative Design (Beijing) Co., Ltd. Aims to Integrate Buddhist Faith with Interior Design
Beijing, China–(Newsfile Corp. – March 8, 2022) – Chinese interior designer Duan Yuan, who is…
Global Aerospace and Defense Company Selects CoreSite to Support Its Modern Hybrid IT Strategy
Organization Requirements Include Secure, Reliable Colocation and Native Cloud Onramps in a State-of-the-Art Data Center…
CPI Card Group Inc. Reports Fourth Quarter and Full Year 2021 Results
Fourth Consecutive Year of Strong Sales Growth; Full Year Net Sales Increased 20% to $375.1…
DNA Script Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Company’s enzymatic DNA printing on demand technology recognized among top-ranked in the biotech category. SOUTH…
Heliogen Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Concentrated solar thermal energy company joins the ranks of past winners including Microsoft, SpaceX, Moderna,…
Veritone’s AI-powered iDERMS Solution Selected by Competitive Power Ventures for Energy Market Price Forecasting in PJM
The solution will provide day-ahead and real-time energy price forecasting to maximize the value and…
Rocket Pharmaceuticals Appoints Jessie Yeung as Vice President of Investor Relations and Corporate Finance
CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable…
Step Named to Fast Company’s List of the World’s Most Innovative Companies for 2022
Step joins the ranks of legendary companies like SpaceX, Shopify, Snap and more. PALO ALTO,…
ABBYY Strengthens Partner Ecosystem with ABBYYOne, a New Global Program to Drive Intelligent Process Automation (IPA)
CHARLOTTE, N.C.–(BUSINESS WIRE)–#ABBYYOne–ABBYY launched its new global partner program, ABBYYOne, to enable partners to accelerate…
Google to Acquire Mandiant
Acquisition to bring Google speed and scale to Mandiant’s unparalleled intelligence and expertise – at…
Ryder to Reshape Inbound Supply Chain for Southern Glazer’s Wine & Spirits
The largest distributor of beverage alcohol in North America turns to Ryder’s supply chain team…
United States DoD Artificial Intelligence: Computing Power and AI Advancements Ensure Broad and Effective Defense Capabilities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United States DoD Artificial Intelligence Growth Opportunities” report has been added to ResearchAndMarkets.com’s…
Seeking a high-growth career in tech? Data Center Career Pathfinder makes it easier with help from Google, Meta, and Microsoft
The first comprehensive taxonomy of digital infrastructure job roles launches to help expand and diversify…
Go!Foton To Announce EKO Product Availability, Enhancements At OFC
SAN DIEGO–(BUSINESS WIRE)–Go!Foton, a world leader in optical components and connectivity solutions for carriers and…
NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
VAXIMM technology enables fast generation and delivery of personalized T-cell cancer vaccines and may overcome…
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of…